The company's activity includes research, design and development, production, consulting, and marketing of products in the biotechnological, medical and pharmaceutical fields. The company's purpose also includes research, design and development, production, consulting, and marketing of biomaterials, medical devices (such as solid, semi-solid and injectable hydrogels), systems for controlled release of active principles (such as micro and nanoparticles), systems for hosting and transporting human cells for the regeneration of human tissues and organs, and more generally combined systems for applications in regenerative medicine and tissue engineering, with particular attention to applications in the field of central nervous system and spinal cord regeneration. The company's purpose also includes research, design and development, production, consulting, and marketing of composite systems for the regeneration of damaged spinal cord. The company may also acquire, sell, and exploit patents, licenses, and know-how of any kind. The company may trade in goods (import-export) or services of any kind. The company may assume representations, participate in other companies, open branches both in Switzerland and abroad, and perform all operations that have a direct or indirect relationship with the company's purpose. The company may acquire, sell, and lease real estate both in Switzerland and abroad. The company may receive and grant loans, create mortgage certificates on its own properties. The company may provide services to third parties and execute financial transactions on its own account, both in Switzerland and abroad.